Kura Oncology was named a finalist for the Excellence in Patient Recruitment & Engagement category at the 2024 Citeline Awards.
The 8th Annual Citeline Awards showcased excellence in clinical trial design, technological advancements, results and more, highlighting the work of individuals and teams across our sector. Along with six other incredible biopharma teams, our work in patient recruitment and engagement was recognized as industry leading and innovative.
What makes Kura stand out? The Kura team is deeply committed to listening and learning from the patient community through its close relationships – with investigators, advocacy groups and directly with patients – and meeting patient needs through educational and support efforts.
Congratulations to all the finalists and winners. See the full list here.
